ECT2 and neoplasm: We also investigated the pathways for CEP55 molecular interactions and nominated its interaction with three proteins—KIF14, KIF23, and ECT2—as a potential pathway for tumor progression that can be targeted for therapeutic interventions where computational tools can also be employed through a cheminformatics approach to analyze the binding of several molecules to these targets, an approach that could be translated later to effective anticancer drugs.